Segawa Syndrome is a rare genetic disorder characterized by a progressive movement disorder. The ICD10 code for Segawa Syndrome is G21.8. In the previous ICD9 coding system, it was classified under the code 333.79. Segawa Syndrome affects the nervous system and can cause muscle stiffness, tremors, and difficulty with coordination. Early diagnosis and treatment are crucial for managing symptoms and improving quality of life.
Segawa syndrome, also known as dopa-responsive dystonia, is a rare genetic disorder characterized by involuntary muscle contractions and abnormal postures. It is caused by a deficiency of an enzyme called GTP cyclohydrolase 1, which leads to reduced dopamine production in the brain.
In the International Classification of Diseases, 10th Revision (ICD-10), Segawa syndrome is classified under the code G24.1. This code falls under the category of "Other dystonia," which includes various types of dystonia not specifically classified elsewhere. The code G24.1 specifically denotes "Dystonia due to genetic disorders," highlighting the genetic nature of Segawa syndrome.
In the previous version, the International Classification of Diseases, 9th Revision (ICD-9), Segawa syndrome was classified under the code 333.6. This code fell under the category of "Other extrapyramidal diseases and abnormal movement disorders," which encompassed various movement disorders not classified elsewhere.
It is important to note that the transition from ICD-9 to ICD-10 occurred on October 1, 2015, and the use of ICD-10 codes became mandatory for medical coding and billing purposes. Therefore, healthcare professionals and medical coders now primarily utilize the ICD-10 code G24.1 to identify and document cases of Segawa syndrome.
If you suspect that you or someone you know may have Segawa syndrome, it is crucial to consult with a healthcare professional for an accurate diagnosis, appropriate treatment, and ongoing management of the condition.